UNSPSC 51283218: Mepartricin a

This classification denotes a macrolide antibiotic with the molecular formula C60H88N2O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L13V8793FQ, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-n47-methyl-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin a, which bears US NIH Compound Identifier 3009010. European Medicines Agency schedules mepartricin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03153MIG.

Most nations, for tariff purposes, schedule mepartricin a under HS 29419000. SMILES: C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC\2CC3C(C(CC(O3)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC(C(/C=C/C=C/C=C/C=C/C=C/C=C/C=C2)C)C(C)CCC(CC(=O)C4CCC(CC4)NC)O)O)O)O)O)O)O)O)C(=O)OC)O)N)O.

UNSPSC 51283218 Mepartricin a is a Commodity code under which state and local governments procure pharmaceutical products, though the recent opportunities block shows limited activity directly aligned with the code's nominal scope. The two recent records present a mismatch: the Illinois Department of Public Health's August 2026 award to Chartwell Rx LLC was for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through a piggyback contract via the MMCAP Infuse consortium (a completed award, not an open solicitation), while Seminole County, Florida's June 2026 IFB was for Naloxone and Safe Drug Deactivation Systems. Neither opportunity directly involves Mepartricin a. The code sees procurement activity from state health departments and county government entities, but the recent solicitations show that state and local buying under this specific pharmaceutical category is sparse and geographically scattered.

Activity is concentrated in Illinois and Florida based on the two most recent records, with the Illinois contract representing $2,999,999.11 over three years and Seminole County procuring 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year initial term with one-year renewal option. The Illinois award to Chartwell Rx LLC was made through an Invitation for Bid process with a 12-month initial term and years 2 and 3 renewal options, while Seminole County's IFB closed July 26, 2023 (note: the due date appears inconsistent with the posting date of June 30, 2026, suggesting a data quality issue in the source). The code shows little recent relevant activity, and the two opportunities recorded do not align with Mepartricin a procurement specifically, indicating this Commodity code may warrant closer attention to actual solicitation language before pursuit.